These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12362654)

  • 1. Positron emission tomography scanning: a primer.
    Walker RC; Weiss DW; Purnell GL; Forte KF
    J Ark Med Soc; 2002 Oct; 99(4):119-21. PubMed ID: 12362654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron-emitting radiopharmaceuticals: how safe are they?
    Silberstein EB
    Cancer Biother Radiopharm; 2001 Feb; 16(1):13-5. PubMed ID: 11279793
    [No Abstract]   [Full Text] [Related]  

  • 3. Positron emission tomography (PET) in the evaluation of patients with cancer.
    Godwin HA; Zuger JH
    Trans Am Clin Climatol Assoc; 1999; 110():181-94. PubMed ID: 10344016
    [No Abstract]   [Full Text] [Related]  

  • 4. Isotopic labeling with short-lived radionuclides represents the future for clinical PET imaging. For the proposition.
    Harkness B
    Med Phys; 2002 Dec; 29(12):2897-8. PubMed ID: 12512725
    [No Abstract]   [Full Text] [Related]  

  • 5. [New functional imaging technique "positron emission tomography"].
    Tamaki N
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):101-4. PubMed ID: 9612703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine.
    Schelbert HR; Hoh CK; Royal HD; Brown M; Dahlbom MN; Dehdashti F; Wahl RL
    J Nucl Med; 1998 Jul; 39(7):1302-5. PubMed ID: 9669415
    [No Abstract]   [Full Text] [Related]  

  • 7. Oncological applications of FDG PET imaging.
    Delbeke D
    J Nucl Med; 1999 Oct; 40(10):1706-15. PubMed ID: 10520713
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging?
    Hoegerle S; Juengling F; Otte A; Altehoefer C; Moser EA; Nitzsche EU
    Radiology; 1998 Oct; 209(1):253-8. PubMed ID: 9769840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical oncologic positron emission tomography: an introduction.
    Turkington TG; Coleman RE
    Semin Roentgenol; 2002 Apr; 37(2):102-9. PubMed ID: 12134363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography in cancer patient management.
    Wahl RL
    Cancer J Sci Am; 1999; 5(4):205-7. PubMed ID: 10439163
    [No Abstract]   [Full Text] [Related]  

  • 11. 2003 SNM Highlights Lecture: From proof of principle to proof of value.
    Wagner HN
    J Nucl Med; 2003 Aug; 44(8):11N-36N. PubMed ID: 12934586
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis of colorectal cancer with FDG-PET].
    Uno K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():168-72. PubMed ID: 14574875
    [No Abstract]   [Full Text] [Related]  

  • 13. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations.
    Gordon BA; Flanagan FL; Dehdashti F
    AJR Am J Roentgenol; 1997 Dec; 169(6):1675-80. PubMed ID: 9393189
    [No Abstract]   [Full Text] [Related]  

  • 14. [Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology].
    Soepenberg O
    Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1979-80. PubMed ID: 11048563
    [No Abstract]   [Full Text] [Related]  

  • 15. [Technique and indications in pediatric oncology. Positron emission tomography with 18F-fluorodeoxyglucose].
    Foehrenbach H; Edeline V; Bonardel G; Neuenschwander S
    Arch Pediatr; 2004 Apr; 11(4):378-82. PubMed ID: 15051101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography in oncology: the most sophisticated imaging technology.
    Lacić M; Maisey MN; Kusić Z
    Acta Med Croatica; 1997; 51(1):1-9. PubMed ID: 9115096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET scanning in malignancy: infant, adolescent or mature citizen?
    Brennan MF
    Ann Surg; 2001 Mar; 233(3):320-1. PubMed ID: 11224618
    [No Abstract]   [Full Text] [Related]  

  • 18. Feasibility of a short acquisition protocol for whole-body positron emission tomography with fluorine-18 fluorodeoxyglucose.
    Paul AK; Tatsumi M; Fujino K; Hashikawa K; Nishimura T
    Eur J Nucl Med; 2001 Nov; 28(11):1697-701. PubMed ID: 11702113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative positron emission tomography imaging to measure tumor response to therapy: what is the best method?
    Mankoff DA; Muzi M; Krohn KA
    Mol Imaging Biol; 2003; 5(5):281-5. PubMed ID: 14630508
    [No Abstract]   [Full Text] [Related]  

  • 20. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.